Go to SC301 Clinic AI Consultation Request
Sollea AI Consultation
Sollea AI Consultation
Go to SC301 Clinic AI Consultation Request
Skip to main content
301 blog

Advanced Regenerative Medicine Act Passed! SC301 Director Shin Dong-jin's Advanced Medical Story

By 2025-04-14March 10th, 9No Comments

💡 “77.48% Engraftment Rate, Opening the Future of Stem Cell (SVF) Cosmetic Surgery” – The Dawn of the Era of Advanced Regenerative Medicine Presented by SC301 Director Shin Dong-jin

안녕하세요,

This is the SC301 Seongchelin Guide.

Today, to the Korean regenerative medicine community

I would like to share some good news.

October 2025, 2,

South Korean stem cells

The landscape of treatment changes.

It is precisely 'advanced regenerative medicine and

첨단바이오의약품

Act on Safety and Support,

The so-called Advanced Biomedical Engineering Act amendment

This is because it will be fully implemented one year after the promulgation.

Now, the patient's own cells

With minimal manipulation

It can be used in regenerative medicine, and

Patients with serious, rare, or incurable diseases

As 'general treatment' rather than a clinical trial

stem cell-based therapy

You will be able to receive it.

As a beneficiary and pioneer of this law,

Stem cells since 2007

Researching plastic surgery

SC301's that have been implemented

Director Shin Dong-jin says.

This amendment to the law is for the past 17 years

To me, who has been with stem cells

It is good news, like welcome rain in a drought.


🧬 The history of stem cell (SVF) breast augmentation, at its center is SC301

In 2007, the first plastic surgery clinic in Korea

Established the 'Stem Cell (SVF) Transplant Plastic Surgery Research Institute', and

Founded the 'Korean Society of Stem Cell Plastic Surgery'

Through academic seminars and live surgery

SC301, which has widely disseminated surgical techniques.

In particular, to increase the engraftment rate of stem cells

The continuous research has received worldwide attention.

💡 Average stem cell engraftment rate 77.48% – Published in the University of Oxford Journal (2020) and the Annals of Plastic Surgery (2023).

The general autologous fat graft survival rate

While it remains at only 10~15%,

SC301's stem cell (SVF) regeneration is astonishing

It boasts a graft survival rate more than 7 times higher.

This result is not merely 'technology',

Long trial and error and billions of won

Infrastructure investment and training of skilled personnel

It is also an achievement.


🛠 Stem Cell (SVF) Cosmetic Surgery: 'Sincerity' is More Important Than Technology

How to use stem cells

The key is how you handle it.

SC301 is automatic

Reverting to manual mode,

We adhere to the extraction method that yielded the highest performance.

Manual extraction: High purity by specialized personnel

We extract stem cells directly.

Golden Ratio Formula: Stem cells and

Combines fat cells in the optimal ratio.

Shortest Transplant Time: For areas requiring volume

Immediate transplantation increases the survival rate.

Without such a sophisticated process

It cannot be called real stem cell (SVF) plastic surgery.


🧊 -196 degrees, the SC301 where time stops

Cryogenic cell banking

The future of stem cell (SVF) therapy is being prepared now.

SC301 was the first for private practitioners in Korea in 2017

We have introduced an 'ultra-low temperature cell banking system'.

With liquid nitrogen at minus 196 degrees

Stem cells can be stored for a long time.

The infinite potential of anti-aging and incurable disease treatment

It is opening up possibilities.

From sterile operating rooms to stem cell counters and 3D volume imaging equipment, SC301, certified as a dedicated research and development department, is a 'real research hospital'.


🔭 Where is the SC301 Heading in 2025?

In line with the upcoming implementation of the Cheomba Act,

SC301 is a regenerative medicine institution under the Ministry of Health and Welfare

Preparations for the designation are in full swing.

Facilities, equipment, and personnel are already fully equipped.

All that remains now is organizing the technical documentation.

SC301 will be in the future

Expansion of therapeutic indications for cancer, rare diseases, etc.

Resumption of attracting overseas patients (especially the Chinese market)

Activation of anti-aging treatments, etc.

Toward an even broader regenerative medicine market

We plan to take a leap forward.


The Future of Regenerative Medicine, Together with Medical Consumers

Stem cell (SVF) plastic surgery is

It is not just a simple cosmetic procedure.

Improving the quality of life,

Providing satisfaction without the need for revision surgery

It is a culmination of medical innovation.

SC301 upholds technology and authenticity at its core,

We aim to realize true medical care.

Accurate treatment for patients who need it,

"Most safely."

SC301's tomorrow is your tomorrow.